TREATMENT OF STEROID-RESISTANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH PULSE METHYLPREDNISOLONE AND ALKYLATING-AGENTS

被引：143

作者：

MENDOZA, SA

REZNIK, VM

GRISWOLD, WR

KRENSKY, AM

YORGIN, PD

TUNE, BM

机构：

[1] Department of Pediatrics, University of California, San Diego, La Jolla, California

[2] Department of Pediatrics, Stanford University School of Medicine, Stanford, California

来源：

PEDIATRIC NEPHROLOGY | 1990年 / 4卷 / 04期

关键词：

Alkylating agents; Chronic renal failure; Focal segmental glomerulosclerosis; Methylprednisolone; Nephrotic syndrome; Proteinuria;

D O I：

10.1007/BF00862503

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

In children, steroid-resistant nephrotic syndrome due to focal segmental glomerulosclerosis (FSGS) is frequently a progressive condition resulting in end-stage renal disease. There have been no reports of effective treatment for this condition. For the past several years, the Pediatric Nephrology services at the University of California, San Diego and Stanford University Schools of Medicine have treated these patients with a protocol involving infusions of high doses of methylprednisolone, often in combination with oral alkylating agents. Twenty-three children have been treated in this manner with a follow-up of 46±5 months. Twelve of these children are in complete remission. Six have minimal to moderate proteinuria. Four children remain nephrotic. Each of these children has a normal glomerular filtration rate. One child developed chronic renal failure and subsequently died while on dialysis. These results appear significantly better than previous series of children with FSGS. A controlled, multi-center trial of this protocol has been proposed. © 1990 IPNA.

引用

页码：303 / 307

页数：5

共 29 条

[1]

Habib R., Focal glomerular sclerosis, Kidney Int, 4, pp. 355-361, (1973)

[2]

Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group, Kidney Int, 27, pp. 442-449, (1985)

[3]

Kohaut E.C., Singer D.B., Hill L.L., The significance of focal glomerular sclerosis in children who have nephrotic syndrome, Am J Clin Pathol, 66, pp. 545-550, (1976)

[4]

Arbus G.S., Poucell S., Bacheyie G.S., Bauman R., Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response, J Pediatr, 101, pp. 40-45, (1982)

[5]

Tejani A., Nicastri A.D., Sen D., Chen C.K., Phadke K., Adaon O., Butt K.M., Long-term evaluation of children with nephrotic syndrome and focal segmental glomerular sclerosis, Nephron, 35, pp. 225-231, (1983)

[6]

Cameron J.S., Turner D.R., Ogg C.S., Chantler C., Willia D.G., The long-term prognosis of patients with focal segmental glomerulosclerosis, Clin Nephrol, 10, pp. 213-218, (1978)

[7]

Halevy J., Hayslett J.P., Clinical features and course of focal glomerulosclerosis, The progressive nature of renal disease, pp. 189-201, (1986)

[8]

Fine R., Renal transplantation in children, Nephron, 47, pp. 81-86, (1987)

[9]

Broyer M., Gagnadoux M.F., Guest G., Beurton D., Niaudet P., Habib R., Busson M., Kidney transplantation in children: results of 383 grafts performed at Enfants Malades Hospital from 1973 to 1984, Adv Nephrol, 16, pp. 307-333, (1987)

[10]

Griswold W.R., Tune B.M., Reznik V.M., Vazquez M., Prime D.J., Brock P., Mendoza S.A., Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents, Nephron, 46, pp. 73-77, (1987)

← 1 2 3 →